Our rapidly growing specialty, discovery-based CRO, is located in Worcester, MA and serves as our flagship site for North American business and is near one of the world’s premier life sciences hubs. We offer an extensive portfolio of preclinical research services from in vitro analyses, early discovery and proof-of-concept to discovery toxicology.
Nonclinical capabilities include: pharmacokinetics, lead compound screening, proof of concept, efficacy assessment, pharmacology, mechanism of action, and early lead optimization. Biomere also provides supportive colony maintenance, backup colony support and on site room use agreements. Visit CRO Expertise to review an extensive list of our capabilities.
